Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Coexisting pulmonary aspergillosis and tuberculosis in a post-COVID-19 patient is rare. Here, we are going to report a case of combined pulmonary aspergillosis and tuberculosis in a 51-year-old female who was previously diagnosed with COVID-19 pneumonia. The patient was treated with voriconazole and anti-tuberculosis agents.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11245357 | PMC |
| http://dx.doi.org/10.18502/ijm.v16i3.15800 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Three Biologic-Naïve Patients with Allergic Bronchopulmonary Aspergillosis Showing Significant Clinical Improvement with Tezepelumab.
J Asthma Allergy
August 2025
Division of Respiratory Medicine, Department of Internal Medicine, Shiga University of Medical Science, Otsu, Japan.
Allergic bronchopulmonary aspergillosis is characterized by hypersensitivity to spp. and often causes intractable asthma. Studies have been conducted on biologics administered to patients with allergic bronchopulmonary aspergillosis; however, treatment may not always be successful.
View Article and Find Full Text PDFImproving Diagnostic Sensitivity of Chronic Pulmonary Aspergillosis Using Species-Specific IgG.
Mycoses
September 2025
Doodhadhari Burfani Hospital, Haridwar, India.
Background: Chronic pulmonary aspergillosis (CPA) is most commonly caused by Aspergillus fumigatus (AF-CPA). Serum A. fumigatus-IgG, a pivotal investigation for diagnosing CPA, misses 10%-15% of CPA cases.
View Article and Find Full Text PDFDuo biologic therapy using mepolizumab and omalizumab in refractory ABPA: two cases.
Allergy Asthma Clin Immunol
September 2025
Department of Physiological Science, University of California, 986 N Center Street, Orange, Los Angeles, CA, 90095, USA.
Background: Allergic bronchopulmonary aspergillosis (ABPA) presents with a wide range of symptom severity, with severe disease manifestations being harder to control through conventional inhalers. While corticosteroids remain a standard treatment option, their use is often hindered by significant adverse side effects. This case series discusses a novel treatment of duo-administration of monoclonal antibodies for two patients that reduced their exacerbations, spared the use of steroids, and improved their quality of life.
View Article and Find Full Text PDFA patient with severe fever with thrombocytopenia syndrome complicated with intracranial and pulmonary aspergillosis.
IDCases
August 2025
Department of Neurosurgery, The Sixth People's Hospital of Shenyang, Shenyang, China.
Some patients with severe fever with thrombocytopenia syndrome (SFTS) develop complications including viral encephalitis and fungal infections, with a mortality rate reaching 44.7 %. In this case, the patient was admitted on Day 5 of illness, with symptoms of apathy and a delayed response.
View Article and Find Full Text PDFDiagnosis and treatment of pulmonary infection secondary to empyema complicated with lung cancer: a case report.
Front Med (Lausanne)
August 2025
Department of Respiratory and Critical Care Medicine, Yantai Yuhuangding Hospital, Yantai, China.
Background: This study aimed to explore the clinical characteristics, diagnosis, and management of Invasive Pulmonary (IPA) complicating empyema in a patient with lung cancer.
Case Presentation: We analyzed the clinical manifestations, bronchoscopic findings, and therapeutic approaches, including anti-infective and anti-tumor treatments, in a patient diagnosed with IPA-associated empyema and lung cancer. Histopathological examination of bronchoscopic biopsy specimens confirmed pulmonary adenocarcinoma, while bronchoalveolar lavage fluid cultures identified .